Testosterone Signals through mTOR and Androgen Receptor to Induce Muscle Hypertrophy
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
PURPOSE: The anabolic hormone testosterone induces muscle hypertrophy, but the intracellular mechanisms involved are poorly known. We addressed the question whether signal transduction pathways other than the androgen receptor (AR) are necessary to elicit hypertrophy in skeletal muscle myotubes. METHODS: Cultured rat skeletal muscle myotubes were preincubated with inhibitors for ERK1/2 (PD98059), PI3K/Akt (LY294002 and Akt inhibitor VIII) or mTOR/S6K1 (rapamycin), and then stimulated with 100 nM testosterone. The expression of α-actin and the phosphorylation levels of ERK1/2, Akt and S6K1 (a downstream target for mTOR) were measured by Western blot. mRNA levels were evaluated by real time RT-PCR. Myotube size and sarcomerization were determined by confocal microscopy. Inhibition of AR was assessed by bicalutamide. RESULTS: Testosterone-induced myotube hypertrophy was assessed as increased myotube cross-sectional area (CSA) and increased α-actin mRNA and α-actin protein levels, with no changes in mRNA expression of atrogenes (MAFbx and MuRF-1). Morphological development of myotube sarcomeres was evident in testosterone-stimulated myotubes. Known hypertrophy signaling pathways were studied at short times: ERK1/2 and Akt showed an increase in phosphorylation status after testosterone stimulus at 5 and 15 min, respectively. S6K1 was phosphorylated at 60 min. This response was abolished by PI3K/Akt and mTOR inhibition but not by ERK1/2 inhibition. Similarly, the CSA increase at 12 h was abolished by inhibitors of the PI3K/Akt pathway as well as by AR inhibition. CONCLUSIONS: These results suggest a crosstalk between pathways involving fast intracellular signaling and the AR to explain testosterone-induced skeletal muscle hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350101 · Cited by 1,659
Baar, K., & Esser, K. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.1.c120 · Cited by 726
Chen, J., Zheng, X. F., Brown, E. J., & Schreiber, S. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4947 · Cited by 556
Singh, R., Artaza, J. N., Taylor, W. E., Gonzalez-Cadavid, N. F., & Bhasin, S. (2003) · Endocrinology · doi:10.1210/en.2003-0741 · Cited by 555
Non-genomic actions of androgens
Foradori, C. D., Weiser, M. J., & Handa, R. J. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.10.005 · Cited by 493
Sinha-Hikim, I., Artaza, J., Woodhouse, L., Gonzalez-Cadavid, N., Singh, A. B., Lee, M. I., Storer, T. W., Casaburi, R., Shen, R., & Bhasin, S. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00502.2001 · Cited by 464
Aging impairs contraction-induced human skeletal muscle mtorc1 signaling and protein synthesis
Fry, C. S., Drummond, M. J., Glynn, E. L., Dickinson, J. M., Gundermann, D. M., Timmerman, K. L., Walker, D. K., Dhanani, S., Volpi, E., & Rasmussen, B. B. (2011) · Skeletal Muscle · doi:10.1186/2044-5040-1-11 · Cited by 351
Sinha-Hikim, I., Cornford, M., Gaytan, H., Lee, M. L., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0357 · Cited by 318
Estrada, M., Espinosa, A., Müller, M., & Jaimovich, E. (2003) · Endocrinology · doi:10.1210/en.2002-0164 · Cited by 264
Cited by
Cancer cachexia: molecular mechanisms and treatment strategies
Setiawan, T., Sari, I. N., Wijaya, Y. T., Julianto, N. M., Muhammad, J. A., Lee, H., Chae, J. H., & Kwon, H. Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01454-0 · Cited by 315
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications
Ostrovidov, S., Hosseini, V., Ahadian, S., Fujie, T., Parthiban, S. P., Ramalingam, M., Bae, H., Kaji, H., & Khademhosseini, A. (2014) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2013.0534 · Cited by 302
Kraemer, W. J., Ratamess, N. A., Hymer, W. C., Nindl, B. C., & Fragala, M. S. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00033 · Cited by 300
Muscle metabolism and atrophy: let’s talk about sex
Rosa-Caldwell, M. E., & Greene, N. P. (2019) · Biology of Sex Differences · doi:10.1186/s13293-019-0257-3 · Cited by 202
“Specifically, it has been demonstrated that testosterone action can activate mTOR through androgen-mediated action of androgen receptor to activate PI3k/Akt signaling [107].”
BackgroundAcne vulgaris: The metabolic syndrome of the pilosebaceous follicle
Melnik, B. C. (2018) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2017.09.006 · Cited by 189
Recovery responses of testosterone, growth hormone, and IGF-1 after resistance exercise
Kraemer, W. J., Ratamess, N. A., & Nindl, B. C. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00599.2016 · Cited by 181
“, mechano-growth factor and IGF-1Ea (56, 77), and Akt/4 mammalian target of rapamycin (mTOR) pathway activation (7, 94); downregulate and upregulate myostatin gene expression (10, 16); downregulate Acvr2b receptor mRNA (16); inhibit forkhead box O (FoxO) family of transcription factors catabolism (94); and downregulat…”
BackgroundDyle, M. C., Ebert, S. M., Cook, D. P., Kunkel, S. D., Fox, D. K., Bongers, K. S., Bullard, S. A., Dierdorff, J. M., & Adams, C. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556241 · Cited by 138
Landen, S., Hiam, D., Voisin, S., Jacques, M., Lamon, S., & Eynon, N. (2023) · The Journal of Physiology · doi:10.1113/jp279499 · Cited by 137
“In both males (Urban et al. 1995; Sheffield-Moore et al. 1999) and females (Smith et al. 2014), testosterone directly activates muscle protein synthesis by triggering the Akt/mTOR pathway (Basualto-Alarcón et al. 2013).”
BackgroundBond, P. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0118-y · Cited by 121
“Interestingly, one study examining the rapid effects of testosterone in cultured rat myotubes directly implicates the PI3K/Akt/mTORC1 pathway as a mediator of androgens’ effect on contractile protein synthesis [46].”
BackgroundAndrogen-mediated regulation of skeletal muscle protein balance
Rossetti, M. L., Steiner, J. L., & Gordon, B. S. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.031 · Cited by 95
“Key Words: Hypertrophy; Atrophy; Anabolic; Catabolic; Testosterone; Autophagy Abbreviations: mTORC1, mechanistic target of rapamycin in complex 1; AR, androgen receptor; DHT, 5α-dihydrotestosterone; TE, testosterone enanthate; TC, testosterone cypionate; ARE, androgen response element; p70S6K1, 70 kD ribosomal protein…”
BackgroundInfluentialHuiberts, R. O., Wüst, R. C. I., & van der Zwaard, S. (2024) · Sports Medicine · doi:10.1007/s40279-023-01943-9 · Cited by 75
“Circulating testosterone levels in males acutely increase following strength exercise [123, 124], which activates muscle protein synthesis via the anabolic Akt/mTOR pathway and androgen receptors [125, 126].”
Horwath, O., Apró, W., Moberg, M., Godhe, M., Helge, T., Ekblom, M., Hirschberg, A. L., & Ekblom, B. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00893.2019 · Cited by 70
“456 While androgen receptors (AR) and the mTOR signaling pathway are recognized as central 457 mediators of testosterone action (3, 36), it has been reported that AR content is greater in type 458 I compared to type II fibers (35), indicative of a mechanism for fiber type-specific responses 459 to testosterone in men.”
BackgroundUrolithin B, a Newly Identified Regulator of Skeletal Muscle Mass
Rodriguez, J., Pierre, N., Naslain, D., Bontemps, F., Ferreira, D., Priem, F., Deldicque, L., & Francaux, M. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12190 · Cited by 70
Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength
Summermatter, S., Bouzan, A., Pierrel, E., Melly, S., Stauffer, D., Gutzwiller, S., Nolin, E., Dornelas, C., Fryer, C., Leighton-Davies, J., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00305-16 · Cited by 66
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
“Chronic activation of S6K1 mediated by mTORc1, inflicts serine phosphorylation of IRS1 leading to reduced insulin sensitivity [152, 153].”
BackgroundInfluentialRossetti, M. L., Esser, K. A., Lee, C., Tomko, R. J., Eroshkin, A. M., & Gordon, B. S. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00177.2019 · Cited by 37
Earp, J. E., Hatfield, D. L., Sherman, A., Lee, E. C., & Kraemer, W. J. (2019) · European Journal of Applied Physiology · doi:10.1007/s00421-019-04178-7 · Cited by 36
Fenugreek and Its Effects on Muscle Performance: A Systematic Review
Albaker, W. I. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13030427 · Cited by 29
Howard, E. E., Margolis, L. M., Berryman, C. E., Lieberman, H. R., Karl, J. P., Young, A. J., Montano, M. A., Evans, W. J., Rodriguez, N. R., Johannsen, N. M., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00157.2020 · Cited by 28
Rossetti, M. L., Steiner, J. L., & Gordon, B. S. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.017 · Cited by 24
Determination and regulation of body composition in elite athletes
Sonksen, P. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2016-096742 · Cited by 23
Combinatory in vitro effects of the β2-agonists salbutamol and formoterol in skeletal muscle cells
Piribauer, M., Jiang, L., Kostov, T., Parr, M., Steidel, S., Bizjak, D. A., Steinacker, J. M., & Diel, P. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.02.007 · Cited by 10
Jiang, L., Piribauer, M., Kostov, T., Steidel, S., Bizjak, D., Steinacker, J., Parr, M., & Diel, P. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.08.007 · Cited by 8
Brunese, M. C., Femminella, G. D., Bencivenga, L., Tafuri, F., Caiazzo, C., Rengo, G., Guerra, G., & Komici, K. (2025) · GeroScience · doi:10.1007/s11357-025-01801-8 · Cited by 4
“Testosterone activates muscle protein synthesis by triggering the Akt/mTOR pathway, inhibits muscle protein degradation, and promotes the recruitment of mesenchymal pluripotent stem cells into the myogenic lineage [42–45].”
Metadata
- Authors
- BASUALTO-ALARCÓN, C., JORQUERA, G., ALTAMIRANO, F., JAIMOVICH, E., & ESTRADA, M.
- Venue
- Medicine & Science in Sports & Exercise
- Published
- 2013-09
- Volume
- 45
- Issue
- 9
- Pages
- 1712-1720
- ISSN
- 0195-9131 (ISSN-L)
- OpenAlex
- W2326039813
- Cited by
- 147
- References
- 16
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.